| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |